Corporate Profile

Corporate Profile


Integrating resources for greater operating synergy

Company Name LSI Medience Corporation
Head office mapTHE KAITEKI Bldg.,
13-4, Uchikanda 1-chome, Chiyoda-ku Tokyo
President and CEO Akio Ito
Paid-in capital 3 billion yen
Sales Revenue 87.8 billion yen(as of March 31,2017)
Primary Business Domains ・Clinical testing (biochemical testing, hematological testing, immunological testing, microbiological testing, genetic testing, pathological and other testing)
・Development, sale, export and import of in vitro diagnostic reagents and instruments
・Preventive medical services
・Medical services
・Drug development support services (Nonclinical study, Clinical study)
・In vitro cell assay (human cell)
・Gene and protein analysis services
・Environmental risk Assesment (pharmaceuticals, agrochemicals, industrial chemicals, food additives and cosmetics)
・Food Safety Support services
・Anti-Doping test (sample analysis by WADA code)
Number of employees
(whole group)
3,501(as of March 31,2017)
As of Jun. 20. 2017
Executives and Operating Executives President and Chief Executive Officer Akio Ito
Managing Executive Officer
Representative Director, Member of the Board
Yoshiaki Shimizu
Managing Executive Officer
Member of the Board
Kazuyuki Kamioka
Executive Officer, Member of the Board Satoru Kusunoki
Member of the Board Seiichi Kiso
Executive Officer Masaharu Akimoto
Executive Officer Takashi Iwasaki
Executive Officer Takashi Kurihara
Executive Officer Hotaka Saito
Executive Officer Takeshi Masuda
Audit & Supervisory Board Member Tadashi Endou
Audit & Supervisory Board Member Kaoru Ooshida



Diagnostics Testing | Nonclinical & Clinical Services | R&D | Food Sanitation & Hygiene Analysis | Doping Tests | Corporate Profile | Quality & Environmental Policy | Recruiting Info